Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-08 4:17 pm Purchase |
2023-11-01 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Opportunities Fund L.P. | 2,823,921 5.200% |
2,823,921 (New Position) |
Filing History |
| 2023-11-03 4:30 pm Purchase |
2023-10-30 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 12,764,393 19.990% |
3,571,579 (+38.85%) |
Filing History |
| 2023-06-14 4:15 pm Unchanged |
2023-05-23 | 13D | Viridian Therapeutics, Inc. VRDN |
Atlas Venture Fund VII L P | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-05-11 4:26 pm Purchase |
2023-05-01 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 2,310,698 5.400% |
419,531 (+22.18%) |
Filing History |
| 2023-02-14 4:59 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 1,891,167 4.700% |
682,116 (+56.42%) |
Filing History |
| 2023-02-14 4:30 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III L.P. | 4,230,621 9.990% |
2,025,353 (+91.84%) |
Filing History |
| 2023-02-14 3:05 pm Sale |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Cormorant Asset Management LP | 1,100,000 2.730% |
-336,322 (-23.42%) |
Filing History |
| 2023-02-14 2:23 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover GP I, LLC | 983,610 2.400% |
983,610 (New Position) |
Filing History |
| 2023-02-14 11:43 am Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BIOTECHNOLOGY VALUE FUND L P | 2,302,094 5.600% |
99,779 (+4.53%) |
Filing History |
| 2023-02-14 08:59 am Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 3,312,974 7.930% |
1,493,285 (+82.06%) |
Filing History |
| 2023-02-13 5:45 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Vivo Opportunity LLC | 1,678,207 4.200% |
378,207 (+29.09%) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Viridian Therapeutics, Inc. VRDN |
The Vanguard Group | 2,114,994 5.250% |
2,114,994 (New Position) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BlackRock Inc. BLK |
2,761,556 6.900% |
2,761,556 (New Position) |
Filing History |
| 2023-01-26 5:03 pm Sale |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Integrated Core Strategies (US) LLC | 785,854 2.000% |
-636,623 (-44.75%) |
Filing History |
| 2022-08-19 4:34 pm Purchase |
2022-08-17 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 9,192,814 19.990% |
5,732,463 (+165.66%) |
Filing History |
| 2022-08-12 12:35 pm Sale |
2022-08-02 | 13G | Viridian Therapeutics, Inc. VRDN |
Frazier Life Sciences Public Fund, L.P. | 300,000 1.100% |
-1,205,200 (-80.07%) |
Filing History |
| 2022-05-31 4:40 pm Purchase |
2022-05-26 | 13G | Viridian Therapeutics, Inc. VRDN |
Integrated Core Strategies (US) LLC | 1,422,477 5.100% |
1,422,477 (New Position) |
Filing History |
| 2022-05-19 4:30 pm Purchase |
2022-05-09 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 1,371,339 5.000% |
1,371,339 (New Position) |
Filing History |
| 2022-02-14 4:32 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Point72 Asset Management, L.P. | 472,864 2.200% |
46,702 (+10.96%) |
Filing History |
| 2022-02-14 4:19 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III L.P. | 2,205,268 9.990% |
262,213 (+13.49%) |
Filing History |